Review
Experimental Models of Inflammatory Bowel Diseases

https://doi.org/10.1016/j.jcmgh.2015.01.006Get rights and content
Under a Creative Commons license
open access

The understanding of the intestinal inflammation occurring in the inflammatory bowel diseases (IBD) has been immeasurably advanced by the development of the now numerous murine models of intestinal inflammation. The usefulness of this research tool in IBD studies has been enabled by our improved knowledge of mucosal immunity and thus our improved ability to interpret the complex responses of mice with various causes of colitis; in addition, it has been powered by the availability of models in which the mice have specific genetic and/or immunologic defects that can be related to the origin of the inflammation. Finally, and more recently, it has been enhanced by our newly acquired ability to define the intestinal microbiome under various conditions and thus to understand how intestinal microorganisms impact on inflammation. In this brief review of murine models of intestinal inflammation, we focus mainly on the most often used models that are, not incidentally, also the models that have yielded major insights into IBD pathogenesis.

Keywords

Cell Transfer Colitis
DSS Colitis
IL10 Deficiency
Murine Colitis Models
NKT Cells
Oxazolone Colitis
TNBS Colitis
TH1 Cells
TH17 Cells
Tregs

Abbreviations used in this paper

bp
binding-protein
DSS
dextran sulfate sodium
Foxp3
forkhead box P3
IBD
inflammatory bowel disease
IFN-γ
interferon-γ
IL
interleukin
LAP
latency-associated protein
NKT
natural killer T
PSA
polysaccharide A
PTEN
phosphatase and tensin homolog on chromosome 10
TGF-β
transforming growth factor-β
TH
T helper cell
TLR
Toll-like receptor
TNBS
2,4,6-trinitrobenzene sulfonic acid
TNF-α
tumor necrosis factor-α
Treg
regulatory T cell

Cited by (0)

Conflicts of interest The authors disclose no conflicts.

Funding This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.